Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 17;14(20):5072.
doi: 10.3390/cancers14205072.

Autophagy in Hematological Malignancies

Affiliations
Review

Autophagy in Hematological Malignancies

Olga García Ruiz et al. Cancers (Basel). .

Abstract

Autophagy is a highly conserved metabolic pathway via which unwanted intracellular materials, such as unfolded proteins or damaged organelles, are digested. It is activated in response to conditions of oxidative stress or starvation, and is essential for the maintenance of cellular homeostasis and other vital functions, such as differentiation, cell death, and the cell cycle. Therefore, autophagy plays an important role in the initiation and progression of tumors, including hematological malignancies, where damaged autophagy during hematopoiesis can cause malignant transformation and increase cell proliferation. Over the last decade, the importance of autophagy in response to standard pharmacological treatment of hematological tumors has been observed, revealing completely opposite roles depending on the tumor type and stage. Thus, autophagy can promote tumor survival by attenuating the cellular damage caused by drugs and/or stabilizing oncogenic proteins, but can also have an antitumoral effect due to autophagic cell death. Therefore, autophagy-based strategies must depend on the context to create specific and safe combination therapies that could contribute to improved clinical outcomes. In this review, we describe the process of autophagy and its role on hematopoiesis, and we highlight recent research investigating its role as a potential therapeutic target in hematological malignancies. The findings suggest that genetic variants within autophagy-related genes modulate the risk of developing hemopathies, as well as patient survival.

Keywords: autophagy; autophagy-related variants; clinical outcomes; disease progression; hematological malignancies; hematopoiesis; patient survival; therapeutic target.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the writing of the manuscript, or in the decision to publish the reviewed material.

Figures

Figure 1
Figure 1
Autophagy pathway. Schematic representation of the autophagy pathway. This complex mechanism is activated by stress signals or starvation and proceeds through a series of steps, including formation of the isolation membrane; membrane nucleation, elongation, and completion of the autophagosome; autophagosome maturation by fusion with a lysosome; and, finally, degradation of autophagic cargoes and recycling of the resulting molecules.

Similar articles

Cited by

References

    1. Taylor J., Xiao W., Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017;130:410–423. doi: 10.1182/blood-2017-02-734541. - DOI - PMC - PubMed
    1. Djavaheri-Mergny M., Giuriato S., Tschan M.P., Humbert M. Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma. Cells. 2019;8:103. doi: 10.3390/cells8020103. - DOI - PMC - PubMed
    1. Shlush L.I. Age-related clonal hematopoiesis. Blood. 2018;131:496–504. doi: 10.1182/blood-2017-07-746453. - DOI - PubMed
    1. Tomasetti C. Drug Resistance. Adv. Exp. Med. Biol. 2014;844:303–316. doi: 10.1007/978-1-4939-2095-2_15. - DOI - PubMed
    1. Costas M.A., Rubio M.F. Autophagy. A strategy for cell survival. Medicina. 2017;77:314–320. - PubMed